News & Events


Recent Firm Activities and Highlights

PAREXEL International
Two PAREXEL Executives Named to 2017 PharmaVOICE 100
08.01.17
BOSTON, August 1, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Sy Pretorius, M.D., Senior Vice President and Chief Scientific Officer, and Evan Demestihas, M.D., RPh, Vice President, Worldwide Head of The Medical Affairs Company (TMAC), have been named to PharmaVOICE magazine’s list of the 100 most inspiring people in the life sciences industry. The honor, published in the July/August 2017 issue of PharmaVOICE, recognizes both leaders for their valuable contributions to the industry and dedication to improving patients’ lives, while also mentoring the next generation of industry leaders. Read Full Release
COTA
Pharma turns to big data to gauge care and pricing
07.11.17
After many years building successful technology businesses, Jeremy Sohn never imagined that at 43 he would find himself on the payroll of a big pharmaceutical company. But 18 months ago he was appointed global head of digital business development and licensing at Swiss drugmaker Novartis. His appointment is evidence of how an industry, slow to respond to the disruption of digitisation, is grasping its importance as it confronts pricing pressures, ever-vaster quantities of patient data and more empowered consumers. Read Full Release
COTA
NJ Health System Pilots IBM Watson for Oncology Decision Support
07.10.17
IBM Watson for Oncology is getting a trial run at Hackensack Meridian Health, which is supplementing the cognitive computing tool with additional clinical decision support software. Read Full Release
Boston Millennia Parters
Dana Callow to Attend Harvard Medical School’s Precision Medicine 2017: Breakaway Business Models
06.21.17
In this year’s conference on Wednesday, June 21 (agenda below), we address the question of how to implement and disseminate these business models head on. Fortunately there are already several enterprises, some of them led by patients themselves, which provide us early answers to these questions. These are featured in our first panel entitled Early Disruptors in Precision Medicine. Read Full Release
COTA
COTA’s Pecora named Executive of the Year at NJBIZ Healthcare Heroes
06.21.17
Dr. Andrew Pecora said he was honored and humbled when he received the Health Care Executive of the Year award at the NJBIZ Healthcare Heroes awards event Tuesday. Pecora, the president of physician services and chief innovation officer at Hackensack Meridian Health, was quick to recognize his colleagues in the crowd as well as the other honorees at the event. Read Full Release
PAREXEL International
PAREXEL International Enters Definitive Agreement to be Acquired by Pamplona Capital Management for $88.10 Per Share in Cash
06.20.17
BOSTON and NEW YORK, June 20, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and Pamplona Capital Management, LLP (Pamplona) today announced that they have entered into a definitive agreement under which Pamplona will acquire all of the outstanding shares of PAREXEL for $88.10 per share in cash in a transaction valued at approximately $5.0 billion, including PAREXEL’s net debt. Read Full Release
COTA
Hackensack Meridian Health taps IBM Watson for help on cancer treatments
06.05.17
IBM Watson Health, Cota Healthcare and Hackensack Meridian Health are partnering to test clinical decision support in cancer treatment, a pilot that will draw on Cota's precision-medicine database and Watson Health's artificial intelligence-enabled evidence-based recommendations. Read Full Release
Odyssey Logistics & Technology
Odyssey Logistics & Technology Recognized by Gartner in Magic Quadrant for North American 3PL
05.18.17
Danbury, Conn. (May 18, 2017) — Odyssey Logistics & Technology Corp. (Odyssey), a global leading logistics provider, today announced that it has been positioned by Gartner, Inc. on the “Magic Quadrant for Third Party Logistics Providers, North America” for 2017. This marks the first time Odyssey has been placed on the Gartner Magic Quadrant. Read Full Release
PAREXEL International
Attend the lunch and learn with PRXL on Key Aspects of the FDA’s Drug Development and Review Programs
05.12.17
MassBio Lunch and Learn: Navigating Accelerated Approvals in Today’s Oncology Drug Development Landscape: Ensuring a Properly Tailored Approached Based on FDA Expectations and Current Trends in Drug Development Read Full Release
BC Platforms
BMP Founders Fund Company BC Platforms Closes $10M Series B
05.10.17
BC Platforms, a world leader in genomic data management solutions, today announces that it has closed a $USD 10 million financing round. The round was led by Debiopharm Innovation Fund in conjunction with Tesi, a Finnish venture capital and private equity company, and was supported by BC Platforms’ existing investors. BC Platforms will use the funds to launch new technologies in 2017 integrating complex clinical and genomic data in order to deliver precision medicine and clinical patient benefits, as well as to grow its existing genomic data management software business worldwide. Read Full Release